Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine
<b>Background/Objectives</b>: Human pluripotent stem cells (hPSCs) and organoid technologies are transforming pharmaceutical research by providing models that more accurately reflect human physiology, genetic variability, and disease mechanisms. This review aims to assess how these syste...
Saved in:
| Main Authors: | Eleanor Luce, Jean-Charles Duclos-Vallee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/7/992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances in the construction of stem cell-derived ovarian organoids
by: Tianyue Zhang, et al.
Published: (2024-12-01) -
Human pluripotent stem cell-derived intestinal organoids for pharmacokinetic studies
by: Takumi Saito, et al.
Published: (2025-06-01) -
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector
by: Z. Du, et al.
Published: (2025-04-01) -
Role of BMPR2 Mutation in Lung Organoid Differentiation
by: Simin Jiang, et al.
Published: (2025-07-01) -
Cerebral organoid research for pediatric patients with neurological disorders
by: Jin Eun, et al.
Published: (2025-04-01)